Search hospitals > Quebec > MONTREAL
The Montreal Children's Hospital of the MUHC
Claim this profileMONTREAL, Quebec H3H 1P3
Global Leader in Leukemia
Global Leader in Lymphoblastic Leukemia-Lymphoma
Conducts research for Tumors
Conducts research for Brain Tumor
Conducts research for Lymphoma
254 reported clinical trials
11 medical researchers
Summary
The Montreal Children's Hospital of the MUHC is a medical facility located in MONTREAL, Quebec. This center is recognized for care of Leukemia, Lymphoblastic Leukemia-Lymphoma, Tumors, Brain Tumor, Lymphoma and other specialties. The Montreal Children's Hospital of the MUHC is involved with conducting 254 clinical trials across 437 conditions. There are 11 research doctors associated with this hospital, such as Sharon B. Abish, Genevieve Legault, MD, Pia Wintermark, MD, and Patricia Fontela, MD.Area of expertise
1Leukemia
Global LeaderStage II
BCR-ABL1 fusion positive
ABL-class fusion positive
2Lymphoblastic Leukemia-Lymphoma
Global LeaderStage II
BCR-ABL1 fusion positive
ABL-class fusion positive
Top PIs
Sharon B. AbishThe Montreal Children's Hospital of the MUHC4 years of reported clinical research
Studies Leukemia
Studies Lymphoblastic Leukemia-Lymphoma
29 reported clinical trials
74 drugs studied
Genevieve Legault, MDMontreal Children's Hospital1 year of reported clinical research
Studies Brain Tumor
Studies Diffuse Intrinsic Pontine Glioma
8 reported clinical trials
12 drugs studied
Pia Wintermark, MDMontreal Children's Hospital4 years of reported clinical research
Studies Traumatic Brain Injury
Studies Neonatal Asphyxia
2 reported clinical trials
2 drugs studied
Patricia Fontela, MDMontreal Children's Hospital5 years of reported clinical research
Studies Vitamin D Deficiency
Studies Septic Shock
2 reported clinical trials
3 drugs studied
Clinical Trials running at The Montreal Children's Hospital of the MUHC
Ovarian Tumors
Germ Cell Tumors
Brain Tumor
Acute Myeloid Leukemia
Craniopharyngioma
Tumors
Testicular Carcinoma
Ovarian Carcinoma
Embryonal Carcinoma
Ovarian Choriocarcinoma
Chemotherapy
for Cancer
This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it developed, it is considered metastatic. Drugs used in chemotherapy, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. The trial studies whether carboplatin or cisplatin is the preferred chemotherapy to use in treating metastatic standard risk germ cell tumors.
Recruiting2 awards Phase 326 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at The Montreal Children's Hospital of the MUHC?
The Montreal Children's Hospital of the MUHC is a medical facility located in MONTREAL, Quebec. This center is recognized for care of Leukemia, Lymphoblastic Leukemia-Lymphoma, Tumors, Brain Tumor, Lymphoma and other specialties. The Montreal Children's Hospital of the MUHC is involved with conducting 254 clinical trials across 437 conditions. There are 11 research doctors associated with this hospital, such as Sharon B. Abish, Genevieve Legault, MD, Pia Wintermark, MD, and Patricia Fontela, MD.